• Explore /
  • Poster
  • / Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).

Abstract Poster

Authors

null

Charlee Nardin

University Hospital Jean Minjoz, Université de Franche-Comté, Inserm RIGHT, Besançon, France

Charlee Nardin , Charlotte Cavalieri , Celeste Lebbe , Cécile Pagès , Emilie Gérard , Jacques Rouanet , Claudia Luisa Bejar Ardiles , Nora Kramkimel , Candice Lesage , Florent Grange , Bertille Bonniaud , Sophie Darras , Yannick Le Corre , Philippe Saiag , Florence Brunet-Possenti , Mélanie Saint-Jean , Henri Montaudie , Mona Amini Adle , Elisa Funck-Brentano , Francois Aubin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 9578)

DOI

10.1200/JCO.2024.42.16_suppl.9578

Abstract #

9578

Poster Bd #

362

Abstract Disclosures

Similar Posters

First Author: Charlee Nardin

First Author: Paolo Antonio Ascierto

First Author: Lorenzo Pilla

First Author: Minke W. Lucas